CRL Prakiraan wutah bathi resik saben saham ing taun iki Charles River Corp

Charles River Laboratories (CRL) attracts elite toxicologists by offering them prestigious careers and cutting-edge equipment. The company is implementing AI modeling and developing gene therapy bioprocessing to accelerate drug development. Moderate cyclicality in R&D budgets is smoothed out by long-term contracts. The YoY net income per share growth rate, as shown on this GURU.Markets chart, confirms the business's resilience, where 11.70 becomes the new value for this metric.

Charles River Laboratories International, Inc. (CRL): Wutah bathi ing taun lumaku saka 04.07.2022 nganti 14.11.2026

Rincian analitis lan laporan data perusahaan Charles River Laboratories (CRL)

- rega saham lan prakiraan rega para ahli:

Rega Charles River Laboratories International, Inc.|CRL - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar Charles River Corp|CRL - Nilai Perusahaan

- data nilai buku modal saham:

Nilai Akuntansi saben Saham Charles River|CRL - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku criver.com|CRL - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Total Utang marang Modal Charles River Laboratories|CRL - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal criver.com|CRL - Utang perusahaan|Rasio utang marang kapitalisasi buku Charles River Corp|CRL - Utang jangka dawa perusahaan|Utang jangka cendhak Charles River|Koefisien jangkoan perantara criver.com

- data bathi resik lan rasio valuasi:

CRL - Penghasilan resik|Penghasilan resik sing dikarepake Charles River Laboratories|CRL - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Charles River Corp|CRL - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Charles River Corp|CRL - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Charles River|CRL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan criver.com|CRL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Charles River Laboratories

- informasi babagan volume dodolan lan pendapatan:

CRL - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan Charles River Laboratories International, Inc.|CRL - Rasio rega marang pendapatan|Rasio rega marang prakiraan pendapatan Charles River Corp

Analisis dhasar perusahaan:Charles River Laboratories International, Inc., CRL

Professional managers utilize net earnings per share dynamics to assess a business's ability to generate value amid changing capital costs. This annual EPS percentage change measures the growth rate of returns, which for Charles River Laboratories (CRL) is supported by its monopoly position in preclinical research and its ability to pass costs onto customers due to inelastic demand.

Pesaing langsung

IQV: Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi saben saham ing taun lumaku Laboratory Corporation of America|Medpace Corp (MEDP) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku ICLR|Wutah bathi resik saben saham ing taun iki evotec.com EVO|Wutah bathi ing taun lumaku FTRE (Fortrea)|Tambahing bathi saben saham ing taun lumaku LFCR|OmniAb Corp - Wutah bathi ing taun lumaku|NOTV - Wutah bathi ing taun lumaku|Avid Bioservices, Inc. (CDMO) - Wutah bathi saben saham ing taun lumaku|catalent.com - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Scorpius Holdings